- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Leo W. Jenkins Cancer Center
Total 858 results
-
H. Lee Moffitt Cancer Center and Research InstituteImmunoRestorationRecruitingHER2-positive Breast CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstitutePfizerRecruiting
-
H. Lee Moffitt Cancer Center and Research InstitutePfizerActive, not recruitingLeptomeningeal Metastases | Leptomeningeal DiseaseUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteAstraZenecaActive, not recruitingSmall-cell Lung Cancer | Small Cell Lung Cancer Extensive StageUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNovartisCompletedMelanoma | Skin CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteGlaxoSmithKlineTerminatedThrombocytopenia | Myelodysplastic Syndrome (MDS)United States
-
H. Lee Moffitt Cancer Center and Research InstituteNovartisCompletedPancreatic CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteCelgeneCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteAstraZenecaCompletedNon-Small Cell Lung CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNovartisCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteSanofiTerminatedProstate CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNovartisCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteNovartisTerminatedMultiple MyelomaUnited States, Puerto Rico
-
H. Lee Moffitt Cancer Center and Research InstituteCephalonTerminated
-
H. Lee Moffitt Cancer Center and Research InstituteCognisCompleted
-
H. Lee Moffitt Cancer Center and Research InstitutePfizerCompletedPhase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue SarcomaLeiomyosarcoma | Fibrosarcoma | Liposarcoma | Malignant Fibrous HistiocytomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteGlaxoSmithKlineRecruitingPenile CarcinomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteBeiGeneRecruitingProstate Cancer | Stage IV Prostate CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstitutePfizerActive, not recruitingRenal Cell Carcinoma Stage IVUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteAstraZenecaTerminatedBreast Cancer | Hormone Receptor Positive TumorUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNovartisCompletedBreast Cancer | Breast Cancer - Female | Breast Cancer - MaleUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNovartisCompletedGraft Versus Host Disease | GVHDUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteBayerCompletedProstate Cancer | Prostate AdenocarcinomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteCelgeneCompletedAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNovartisCompletedGraft-Versus-Host DiseaseUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteCelgeneCompletedMyelomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstitutePfizerTerminated
-
H. Lee Moffitt Cancer Center and Research InstitutePfizerRecruitingMelanoma Stage IV | BRAF V600 Mutation | Melanoma Stage IIIUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteAmgenActive, not recruitingBreast Cancer | Invasive Breast Carcinoma | Invasive Ductal Breast Carcinoma | Ductal CarcinomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteExelixisCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteAstraZenecaTerminatedBladder Cancer | Carcinoma in Situ of BladderUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteCelgeneCompletedMultiple MyelomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteBayerCompletedCancer of the Bile DuctUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteBayerCompletedCholangiocarcinoma | Gastrointestinal Tumor | Gall Bladder Carcinoma | Biliary CarcinomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstitutePfizerCompletedChronic Myelomonocytic Leukemia (CMML) | Myelodysplastic Syndrome (MDS)United States
-
H. Lee Moffitt Cancer Center and Research InstituteSanofiTerminatedPancreatic NeoplasmsUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteGlaxoSmithKlineCompletedCancer CachexiaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteSanofiTerminatedPemetrexed &Oxaliplatin in Patients w Recurrent NSCLCa After Failure to Platinum Based Adjuvant ChemLung CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteBayerCompletedRectal CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstitutePfizerCompleted
-
H. Lee Moffitt Cancer Center and Research InstitutePfizerCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteNovartisTerminatedNeuroendocrine CarcinomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteSanofiCompletedNon-Small Cell Lung CancerUnited States, Germany, Puerto Rico
-
H. Lee Moffitt Cancer Center and Research InstituteGlaxoSmithKlineCompletedRectal NeoplasmsUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNovartisTerminated
-
H. Lee Moffitt Cancer Center and Research InstitutePfizerCompletedTobacco DependenceUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteBayerCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteBayerTerminated
-
H. Lee Moffitt Cancer Center and Research InstitutePfizerCompletedGlioblastoma | Anaplastic AstrocytomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstitutePfizerCompletedNeuroendocrine Tumor | Islet Cell TumorUnited States